Statera Biopharma, Inc. Notes Payable, Current
Statera Biopharma, Inc. had Notes Payable, Current of $6.40 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2022-11-14
- 2022-09-30: Notes Payable, Current $6.40M.
- 2022-06-30: Notes Payable, Current $6.40M.
- 2022-03-31: Notes Payable, Current $5.90M.
- 2021-12-31: Notes Payable, Current $4.58M.
| Period end | Notes Payable, Current |
|---|---|
| 2022-09-30 | $6.40M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $6.40M 10-Q · filed 2022-10-28 |
| 2022-03-31 | $5.90M 10-Q · filed 2022-10-21 |
| 2021-12-31 | $4.58M 10-Q · filed 2022-11-14 |
| 2021-09-30 | $2.88M 10-Q · filed 2021-11-15 |
| 2020-12-31 | $1.90M 10-K · filed 2022-10-06 |
| 2020-12-30 | $1.90M 10-Q · filed 2021-11-15 |
| 2015-12-31 | $0.00 10-K · filed 2016-02-23 |
| 2015-09-30 | $2.13M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $2.84M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $2.74M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $2.64M 10-K · filed 2016-02-23 |
| 2014-09-30 | $735.65K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $481.90K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $892.83K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $351.53K 10-K · filed 2015-02-27 |